Forum

TRUMP EFFECT: Novartis plans to invest $23 billion in US plants as Trump renews drug tariff threatshttps://t.co/2amc25Q44Y

— Rapid Response 47 (@RapidResponse47) April 10, 2025

“This commitment enables Novartis to expand on its current manufacturing, research and technology presence across the country with 10 facilities, including 7 brand new facilities, creating nearly 1,000 new jobs at Novartis and approximately 4,000 additional US jobs. The production capacity will cover both active pharmaceutical ingredients (API) and biologics drug substance, as well as secondary production and packaging,” Novartis stated. Over the next five years, Novartis will: Establish 1 biomedical research innovation hub in San Diego, CA, its second global R&D hub in the US Build 4 new manufacturing facilities in soon-to-be-determined states, including 3 that will make biologics drug substances, drug products, device assembly and packaging, and 1 facility that will make chemical drug substances, oral solids dosage forms and packaging Build 2 new radioligand therapy (RLT) manufacturing facilities in Florida and Texas Expand 3 RLT manufacturing facilities in Indianapolis, IN, Millburn, NJ, and Carlsbad, CA